Adar1 Capital Management, LLC Roivant Sciences Ltd. Transaction History
Adar1 Capital Management, LLC
- $530 Billion
- Q2 2024
A detailed history of Adar1 Capital Management, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 4,150,009 shares of ROIV stock, worth $48.9 Million. This represents 8.28% of its overall portfolio holdings.
Number of Shares
4,150,009
Previous 2,791,870
48.65%
Holding current value
$48.9 Million
Previous $29.4 Billion
49.07%
% of portfolio
8.28%
Previous 6.68%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
315Shares Held
496MCall Options Held
991KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$841 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$815 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$787 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$417 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$346 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...